In September, Nestlé Health Science (a subsidiary of Nestlé) launched a new site with a focus on the role NAD decline plays in the aging process. The company then introduced an energy drink mix containing NAD booster Nicotinamide Riboside “NR” (FAQs) (Reviews) in partnership with Chromadex. How is this new product being positioned?
Month: November 2020
In an interview with Longevity Technology last week, Chromadex CEO Rob Fried discussed the strategy and challenges of selling Nicotinamide Riboside “NR” (FAQs) (Reviews) throughout the world. The following are key quotes:
Chromadex CEO Rob Fried joined The Big Biz Show for the second time in a month to discuss Nicotinamide Riboside “NR” (FAQs) (Reviews), COVID studies, and frequently asked questions from NR consumers. Key quotes:
We know that Hong Kong billionaire Li Ka-Shing is a savvy investor. He’s reportedly made $10B+ on an early investment in ZOOM (ticker: ZM). But does he use ZOOM? We don’t know. What about his investment in small-cap Chromadex? Does he personally take their supplement Nicotinamide Riboside “NR” (FAQs) (Reviews)?
On yesterday’s earning call, Chromadex was asked about demand from sports teams for its NAD boosting vitamin supplement Nicotinamide Riboside “NR” (FAQs) (Reviews). Management responded with the following (courtesy of the Motley Fool):